1. 10 years of interferon beta-1b (Betaferon^®) therapy

   • Ludwig Kappos
   • Hans-Peter Hartung

   INTRODUCTION Pages: iii1 - iii2

2. History of modern multiple sclerosis therapy

   • Fred Lublin

   OriginalPaper Pages: iii3 - iii9

3. Clinical implications of neuropathological findings in multiple sclerosis

   • Wolfgang Brück

   OriginalPaper Pages: iii10 - iii14

4. Prognostic factors for multiple sclerosis: the importance of natural history studies

   • George C. Ebers

   OriginalPaper Pages: iii15 - iii20

5. Genomics and proteomics: role in the management of multiple sclerosis

   • Ludwig Kappos
   • Lutz Achtnichts
   • Raija L. P. Lindberg

   OriginalPaper Pages: iii21 - iii27

6. Long-term experience with interferon beta-1b (Betaferon^®) in multiple sclerosis

   • Barry G. W. Arnason

   OriginalPaper Pages: iii28 - iii33

7. Aggressive multiple sclerosis—is there a role for stem cell transplantation?

   • Eva Havrdova

   OriginalPaper Pages: iii34 - iii37

8. The importance of maintaining effective therapy in multiple sclerosis

   • Luca Durelli
   • Marinella Clerico

   OriginalPaper Pages: iii38 - iii43

9. Early treatment and dose optimisation

   • Hans-Peter Hartung

   OriginalPaper Pages: iii44 - iii50